Your browser doesn't support javascript.
loading
Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas.
Zoi, Ilianna; Karamouzis, Michalis V; Xingi, Evangelia; Sarantis, Panagiotis; Thomaidou, Dimitra; Lembessis, Panayiotis; Theocharis, Stamatios; Papavassiliou, Athanasios G.
Afiliación
  • Zoi I; Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75, M. Asias Street, 11527, Athens, Greece.
  • Karamouzis MV; Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75, M. Asias Street, 11527, Athens, Greece. mkaramouz@med.uoa.gr.
  • Xingi E; First Department of Internal Medicine, 'Laiko' Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece. mkaramouz@med.uoa.gr.
  • Sarantis P; Light Microscopy Unit, Hellenic Pasteur Institute, Athens, Greece.
  • Thomaidou D; Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75, M. Asias Street, 11527, Athens, Greece.
  • Lembessis P; Light Microscopy Unit, Hellenic Pasteur Institute, Athens, Greece.
  • Theocharis S; Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.
  • Papavassiliou AG; Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Breast Cancer Res ; 21(1): 132, 2019 12 03.
Article en En | MEDLINE | ID: mdl-31796128
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Ligando RANK / Receptor Activador del Factor Nuclear kappa-B / Terapia Molecular Dirigida / Receptores ErbB / Antineoplásicos Inmunológicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Ligando RANK / Receptor Activador del Factor Nuclear kappa-B / Terapia Molecular Dirigida / Receptores ErbB / Antineoplásicos Inmunológicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Grecia